General Information of the Protein
Protein ID
PT03321
Protein Name
17-beta-hydroxysteroid dehydrogenase type 3
Secondarily
Protein Name
Estradiol 17-beta-dehydrogenase 2
Short chain dehydrogenase/reductase family 12C member 2
Testicular 17-beta-hydroxysteroid dehydrogenase
Testosterone 17-beta-dehydrogenase 3
Gene Name
HSD17B3
Secondarily
Gene Name
EDH17B3
SDR12C2
Sequence
MGDVLEQFFILTGLLVCLACLAKCVRFSRCVLLNYWKVLPKSFLRSMGQWAVITGAGDGIGKAYSFELAKRGLNVVLISRTLEKLEAIATEIERTTGRSVKIIQADFTKDDIYEHIKEKLAGLEIGILVNNVGMLPNLLPSHFLNAPDEIQSLIHCNITSVVKMTQLILKHMESRQKGLILNISSGIALFPWPLYSMYSASKAFVCAFSKALQEEYKAKEVIIQVLTPYAVSTAMTKYLNTNVITKTADEFVKESLNYVTIGGETCGCLAHEILAGFLSLIPAWAFYSGAFQRLLLTHYVAYLKLNTKVR
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Oxidoreductase
Function
Catalyzes the conversion of 17-oxosteroids to 17beta-hydroxysteroids (PubMed:8075637, PubMed:16216911, PubMed:27927697, PubMed:26545797). Favors the reduction of androstenedione to testosterone (PubMed:16216911, PubMed:27927697, PubMed:26545797). Testosterone is the key androgen driving male development and function (PubMed:8075637). Uses NADPH while the two other EDH17B enzymes use NADH (PubMed:26545797, PubMed:8075637, PubMed:16216911). Androgens such as epiandrosterone, dehydroepiandrosterone, androsterone and androstanedione are accepted as substrates and reduced at C-17 (PubMed:16216911). Can reduce 11-ketoandrostenedione as well as 11beta-hydroxyandrostenedione at C-17 to the respective testosterone forms (PubMed:16216911, PubMed:27927697).
    Show/Hide
Uniprot ID
Primary ID:
P37058

Secondarily ID:
Q5U0Q6
    Show/Hide
Ensembl ID
ENSG00000130948
HGNC ID
HGNC:5212
Subcellular Location
Endoplasmic reticulum
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0386569
(3R,8R,9S,10S,13S,14S)-3-benzyl-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C26H36O2
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0392643
(3R,8R,9S,10S,13S,14S)-3-(2-cyclohexylethyl)-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C27H44O2
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0430648
(3R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-3-propyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C22H36O2
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0378689
(3R,8R,9S,10S,13S,14S)-3-butan-2-yl-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C23H38O2
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0847904
(3R,10S,13S)-3-Methoxy-10,13-dimethyl-3-phenethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C28H40O2
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0405802
(3R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-3-phenyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C25H34O2
 1
1
IC50 = 81 nM
   TI
   LI
   LO
   TS
CP0406436
(3S,8R,9S,10S,13S,14S)-3-(cyclohexylmethyl)-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C26H42O2
 1
1
IC50 = 87 nM
   TI
   LI
   LO
   TS
CP0372629
(3R,8R,9S,10S,13S,14S)-3-cyclohexyl-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C25H40O2
 1
1
IC50 = 97 nM
   TI
   LI
   LO
   TS
CP0404703
(3R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-3-(2-phenylethyl)-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C27H38O2
 1
1
IC50 = 99 nM
   TI
   LI
   LO
   TS
CP0293004
(3R,8R,9S,10S,13S,14S)-3-hexyl-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C25H42O2
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0851303
(3R,10S,13S)-3-Butyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C23H38O2
 1
1
IC50 = 116 nM
   TI
   LI
   LO
   TS
CP0853920
(3R,10S,13S)-3-tert-Butyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C23H38O2
 1
1
IC50 = 142 nM
   TI
   LI
   LO
   TS
CP0378928
(3R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-3-octyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C27H46O2
 1
1
IC50 = 147 nM
   TI
   LI
   LO
   TS
CP0895652
(3R,10S,13S)-3-Benzyl-3-methoxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C27H38O2
 1
1
IC50 = 154 nM
   TI
   LI
   LO
   TS
CP0063737
(3alpha,5beta)-3-hydroxyandrostan-17-one
   Show/Hide
C19H30O2
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0847902
(3R,10S,13S)-3-Benzyl-3-ethoxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C28H40O2
 1
1
IC50 = 352 nM
   TI
   LI
   LO
   TS
CP0881037
(3R,10S,13S)-3-(2-Cyclohexyl-ethyl)-3-methoxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C28H46O2
 1
1
IC50 = 354 nM
   TI
   LI
   LO
   TS
CP0038806
Androst-4-en-3,17-dione, 2
   Show/Hide
C19H26O2
 1
1
IC50 = 758 nM
   TI
   LI
   LO
   TS